Arno Therapeutics, Inc. (ARNI)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 10, 2026
Market Cap4.94K -95.2%
Revenue (ttm)n/a
Net Income-13.70M
EPS-0.38
Shares Out 49.35M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,500
Open0.0001
Previous Close0.0001
Day's Range0.0001 - 0.0001
52-Week Range0.000001 - 0.0002
Beta-16.67
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Arno Therapeutics

Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol ARNI
Full Company Profile